Variables | Pre-COVID-19 period | COVID-19 period | SMD | P value |
---|---|---|---|---|
n | 19,709 | 16,975 | Â | Â |
Age, N, % | Â | Â | 0.021 | 0.649 |
 0–44 | 308 (1.6) | 242 (1.5) |  |  |
 45–54 | 916 (4.6) | 752 (4.4) |  |  |
 55–64 | 1790 (9.1) | 1508 (8.9) |  |  |
 65–74 | 4693 (23.8) | 3986 (23.5) |  |  |
 75–84 | 6702 (34.0) | 5846 (34.4) |  |  |
 85- | 5300 (26.9) | 4641 (27.3) |  |  |
Sex (Female), N, % | 8395 (42.6) | 7234 (42.6) |  < 0.001 | 0.976 |
BMI, N, % | Â | Â | 0.046 | 0.002 |
 < 18.5 | 2264 (11.7) | 1964 (11.7) |  |  |
 18.5–24.9 | 11,111 (57.2) | 9521 (56.8) |  |  |
 25–29 | 3704 (19.1) | 3403 (20.3) |  |  |
 30–34 | 679 (3.5) | 547 (3.3) |  |  |
 35 and over | 693 (3.6) | 600 (3.6) |  |  |
 NA | 970 (5.0) | 714 (4.3) |  |  |
mRS at admission, N, % | Â | Â | 0.028 | 0.324 |
 0 | 8658 (44.1) | 7458 (44.0) |  |  |
 1 | 3650 (18.6) | 3073 (18.1) |  |  |
 2 | 2451 (12.5) | 2186 (12.9) |  |  |
 3 | 1896 (9.6) | 1704 (10.1) |  |  |
 4 | 1936 (9.9) | 1674 (9.9) |  |  |
 5 | 842 (4.3) | 663 (3.9) |  |  |
 Other | 221 (1.1) | 185 (1.1) |  |  |
CCI, N, % | Â | Â | 0.014 | 0.618 |
 0 | 16,717 (84.8) | 14,362 (84.6) |  |  |
 1 | 2538 (12.9) | 2191 (12.9) |  |  |
 2 | 399 (2.0) | 377 (2.2) |  |  |
 3 | 55 (0.3) | 45 (0.3) |  |  |
Admission pathway, N, % | Â | Â | 0.049 | 0.002 |
 Home | 16,315 (82.8) | 14,103 (83.1) |  |  |
 Facility | 1456 (7.4) | 1323 (7.8) |  |  |
 Transfer | 1917 (9.7) | 1524 (9.0) |  |  |
 Else | 21 (0.1) | 25 (0.1) |  |  |
Stroke of onset time, N, % |  |  | 0.052 |  < 0.001 |
 3 days or less | 16,629 (84.6) | 14,438 (85.2) |  |  |
 4–7 days | 928 (4.7) | 861 (5.1) |  |  |
 8 days or more | 1796 (9.1) | 1471 (8.7) |  |  |
 Asymptomatic | 302 (1.5) | 172 (1.0) |  |  |
Ambulance, N, % | 9950 (50.5) | 8853 (52.2) | 0.033 | 0.002 |